Physician profile
Numa Cobb, III
NPI 1447371182
$1,194.45
in general payments reported to CMS, 2019-2025
8 companies · $171 in 2025
The $171 reported for 2025 was more than what a typical Orthodontics and Dentofacial Orthopedics provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $67.00 · 2021: $14.92 · 2022: $290 · 2023: $586 · 2024: $65.32 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $416 · Travel and Lodging: $406.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $416.21 |
| Travel and Lodging | $406.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $473.29 | 2019-2023 | Invisalign |
| USA Angelalign Technology Corp | $454.02 | 2023-2025 | |
| Straumann USA LLC | $116.75 | 2025 | |
| Lightforce Orthodontics, INC. | $70.97 | 2023-2024 | |
| Dentsply Sirona INC | $32.32 | 2021-2022 | |
| Envista Holdings Corporation | $19.87 | 2025 | Spark |
| Nobel Biocare USA | $17.23 | 2023 | Nobelactive |
| American Orthodontics Corporation | $10.00 | 2024-2025 | LP and Ifit Tubes, Radiance, Empower-Ceramic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Numa Cobb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.